Virtual Library

Start Your Search

Zoltán Szállási



Author of

  • +

    P2.04 - Immunooncology (Not CME Accredited Session) (ID 953)

    • Event: WCLC 2018
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/25/2018, 16:45 - 18:00, Exhibit Hall
    • +

      P2.04-08 - Platinum-Based Chemotherapy is Associated with Altered PD-L1 Expression in Lung Cancer (ID 13755)

      16:45 - 18:00  |  Author(s): Zoltán Szállási

      • Abstract
      • Slides

      Background

      While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has been extensively studied, the impact of standard platinum-based chemotherapy on PD-L1 or programmed cell death-1 (PD-1) expression is unknown. The aim of this study was to determine the changes in PD-L1 expression of tumor cells (TC) and immune cells (IC), in PD-1 expression of IC, and in the amount of stromal mononuclear cell infiltration after platinum-based chemotherapy in patients with lung cancer.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      We determined the amount of stromal mononuclear cells and PD-L1/PD-1 expressions by immunohistochemistry in bronchoscopic biopsy samples including 20 adenocarcinomas (ADC), 15 squamous cell carcinomas (SCC), 2 other types of non-small cell lung cancer (NSCLC), and 4 small cell lung cancers (SCLC) together with their corresponding surgical resection tissues after platinum-based chemotherapy.

      4c3880bb027f159e801041b1021e88e8 Result

      PD-L1 expression of TC decreased in 10 patients (24.4%) and increased in 3 patients (7.32%) after neoadjuvant chemotherapy (p=0.051). The decrease in PD-L1 expression, however, was significant only in patients who received cisplatin-gemcitabine combination (p=0.020), while in the carboplatin-paclitaxel group no similar tendency could be observed (p=0.432). There was no difference between ADC and SCC groups. Neither PD-1 expression nor the amount of stromal IC infiltration showed significant changes after chemotherapy.

      8eea62084ca7e541d918e823422bd82e Conclusion

      This is the first study, in which both PD-L1 and PD-1 expression were analyzed together with the amount of stromal IC infiltration in different histological subtypes of lung cancer before and after platinum-based chemotherapy. Our results confirm that chemotherapy decreases PD-L1 expression of TC in a subset of patients, therefore rebiopsy and re-evaluation of PD-L1 expression may be necessary for the indication of immune checkpoint inhibitor therapy.

      6f8b794f3246b0c1e1780bb4d4d5dc53

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.